title: Insulin inhibits human erythrocyte cAMP accumulation and ATP release: role of phosphodiesterase 3 and phosphoinositide 3-kinase.
abstract: In non-erythroid cells, insulin stimulates a signal transduction pathway that results in the activation of phosphoinositide 3-kinase (PI3K) and subsequent phosphorylation of phosphodiesterase 3 (PDE3). Erythrocytes possess insulin receptors, PI3K and PDE3B. These cells release adenosine triphosphate (ATP) when exposed to reduced O(2) tension via a signaling pathway that requires activation of the G protein, Gi, as well as increases in cAMP. Although insulin inhibits ATP release from human erythrocytes in response to Gi activation by mastoparan 7 (Mas 7), no effect on cAMP was described. Here, we investigated the hypothesis that insulin activates PDE3 in human erythrocytes via a PI3K-mediated mechanism resulting in cAMP hydrolysis and inhibition of ATP release. Incubation of human erythrocytes with Mas 7 resulted in a 62 +/- 7% increase in cAMP (n = 9, P < 0.05) and a 306 +/- 69% increase in ATP release (n = 9, P < 0.05), both of which were attenuated by pre-treatment with insulin. Selective inhibitors of PDE3 (cilostazol) or PI3K (LY294002) rescued these effects of insulin. These results support the hypothesis that insulin activates PDE3 in erythrocytes via a PI3K-dependent mechanism. Once activated, PDE3 limits Mas 7-induced increases in intracellular cAMP. This effect of insulin leads, ultimately, to decreased ATP release in response to Mas 7. Activation of Gi is required for reduced O(2) tension-induced ATP release from erythrocytes and this ATP release has been shown to participate in the matching of O(2) supply with demand in skeletal muscle. Thus, pathological increases in circulating insulin could, via activation of PDE3 in erythrocytes, inhibit ATP release from these cells, depriving the peripheral circulation of one mechanism that could aid in the regulation of the delivery of O(2) to meet tissue metabolic need.
authors.affiliation: Department of Pharmacological and Physiological Science, Saint Louis University School of Medicine, St Louis, MO 63104, USA. mhanson@mcw.edu
authors.forename: Madelyn S
authors.initials: MS
authors.lastname: Hanson
authors.forename: Alan H
authors.initials: AH
authors.lastname: Stephenson
authors.forename: Elizabeth A
authors.initials: EA
authors.lastname: Bowles
authors.forename: Randy S
authors.initials: RS
authors.lastname: Sprague
mesh_terms: D000255:Adenosine Triphosphate / Q000097:blood*; D000328:Adult; D002867:Chromones / Q000494:pharmacology; D000077407:Cilostazol; D000242:Cyclic AMP / Q000097:blood*; D054684:Cyclic Nucleotide Phosphodiesterases, Type 3 / Q000097:blood*; D004791:Enzyme Inhibitors / Q000494:pharmacology; D004912:Erythrocytes / Q000187:drug effects* / Q000378:metabolism*; D005260:Female; D019206:GTP-Binding Protein alpha Subunits, Gi-Go / Q000097:blood; D006801:Humans; D066298:In Vitro Techniques; D007328:Insulin / Q000097:blood / Q000494:pharmacology*; D036341:Intercellular Signaling Peptides and Proteins; D008297:Male; D008875:Middle Aged; D008954:Models, Biological; D009025:Morpholines / Q000494:pharmacology; D010100:Oxygen / Q000097:blood; D010455:Peptides / Q000494:pharmacology; D019869:Phosphatidylinositol 3-Kinases / Q000097:blood*; D058987:Phosphodiesterase 3 Inhibitors; D000081082:Phosphoinositide-3 Kinase Inhibitors; D015398:Signal Transduction / Q000187:drug effects; D013777:Tetrazoles / Q000494:pharmacology
chemical_list: D000255:Adenosine Triphosphate; D002867:Chromones; D000077407:Cilostazol; D000242:Cyclic AMP; D054684:Cyclic Nucleotide Phosphodiesterases, Type 3; D004791:Enzyme Inhibitors; D019206:GTP-Binding Protein alpha Subunits, Gi-Go; D007328:Insulin; D036341:Intercellular Signaling Peptides and Proteins; D009025:Morpholines; D010100:Oxygen; D010455:Peptides; D019869:Phosphatidylinositol 3-Kinases; D058987:Phosphodiesterase 3 Inhibitors; D000081082:Phosphoinositide-3 Kinase Inhibitors; D013777:Tetrazoles; C084070:Mas7 protein, synthetic; C085911:2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one
references.citation: Med Sci Monit. 2001 Jul-Aug;7(4):669-74
references.pmid: 11433193
references.citation: Med Biol. 1975 Jun;53(3):148-55
references.pmid: 169441
references.citation: Blood. 1999 Dec 15;94(12):4314-20
references.pmid: 10590076
references.citation: Diabetologia. 1992 Aug;35(8):771-6
references.pmid: 1511805
references.citation: J Biol Chem. 1998 Jan 23;273(4):2273-6
references.pmid: 9442071
references.citation: Acta Physiol Scand. 1998 Mar;162(3):411-9
references.pmid: 9578387
references.citation: Diabetes. 2006 Dec;55(12):3588-93
references.pmid: 17130508
references.citation: Am J Physiol Heart Circ Physiol. 2004 Mar;286(3):H940-5
references.pmid: 14615280
references.citation: J Appl Physiol (1985). 2003 Mar;94(3):1033-8
references.pmid: 12571134
references.citation: Nature. 1992 Mar 12;356(6365):159-61
references.pmid: 1312225
references.citation: Diabetes Care. 2003 Mar;26(3):645-9
references.pmid: 12610015
references.citation: J Appl Physiol (1985). 1996 Aug;81(2):885-94
references.pmid: 8872660
references.citation: Biochem J. 1998 Aug 1;333 ( Pt 3):471-90
references.pmid: 9677303
references.citation: Am J Physiol. 1998 Nov;275(5):H1726-32
references.pmid: 9815080
references.citation: Microcirculation. 2009 Jul;16(5):424-33
references.pmid: 19412833
references.citation: Diabetologia. 2000 Nov;43(11):1439-48
references.pmid: 11126416
references.citation: Methods Find Exp Clin Pharmacol. 1998 Jun;20(5):387-93
references.pmid: 9701776
references.citation: Biochim Biophys Acta. 1980 Oct 16;602(1):78-86
references.pmid: 6251888
references.citation: Med Sci Sports Exerc. 2004 Jan;36(1):35-41
references.pmid: 14707765
references.citation: Biochim Biophys Acta. 1973 Apr 28;304(2):552-9
references.pmid: 4351080
references.citation: Am J Physiol Heart Circ Physiol. 2000 Apr;278(4):H1294-8
references.pmid: 10749727
references.citation: Acta Physiol Scand. 2000 Apr;168(4):551-9
references.pmid: 10759592
references.citation: Am J Physiol Heart Circ Physiol. 2004 Aug;287(2):H748-54
references.pmid: 15072952
references.citation: Diabetes. 1978 Jul;27(7):701-8
references.pmid: 658615
references.citation: Am J Physiol. 1995 Dec;269(6 Pt 2):H2155-61
references.pmid: 8594927
references.citation: Cardiovasc Drug Rev. 2001 Winter;19(4):369-86
references.pmid: 11830753
references.citation: Mol Cell Endocrinol. 1976 Jun-Jul;5(1-2):51-66
references.pmid: 182574
references.citation: Pharmacol Rep. 2005;57 Suppl:222-8
references.pmid: 16415502
references.citation: Trends Endocrinol Metab. 2007 Nov;18(9):350-5
references.pmid: 17959385
references.citation: BMJ. 1991 May 11;302(6785):1122-3
references.pmid: 2043783
references.citation: Endocrine. 2006 Apr;29(2):351-5
references.pmid: 16785612
references.citation: Diabetes. 1995 Jul;44(7):721-6
references.pmid: 7789639
references.citation: Endocrinology. 1998 Jan;139(1):219-27
references.pmid: 9421418
references.citation: Diabetes. 2005 Jan;54(1):166-74
references.pmid: 15616025
references.citation: Endocrinology. 1987 Sep;121(3):972-9
references.pmid: 3040382
references.citation: Am J Physiol Heart Circ Physiol. 2009 May;296(5):H1617-24
references.pmid: 19252089
references.citation: J Am Coll Cardiol. 1996 Mar 1;27(3):567-74
references.pmid: 8606266
references.citation: Am J Physiol Heart Circ Physiol. 2008 Aug;295(2):H786-93
references.pmid: 18586889
references.citation: FEBS Lett. 1994 Aug 22;350(2-3):314-8
references.pmid: 8070584
references.citation: Am J Physiol. 1996 Dec;271(6 Pt 2):H2717-22
references.pmid: 8997335
references.citation: J Biol Chem. 2000 Apr 7;275(14):10093-8
references.pmid: 10744689
references.citation: Eur J Biochem. 2000 Feb;267(4):955-62
references.pmid: 10672002
references.citation: J Biol Chem. 1990 Aug 25;265(24):14176-86
references.pmid: 2117607
references.citation: Am J Physiol Heart Circ Physiol. 2001 Jun;280(6):H2833-9
references.pmid: 11356642
references.citation: Mol Cell Biol. 1999 Sep;19(9):6286-96
references.pmid: 10454575
references.citation: Pharmacol Ther. 2006 Mar;109(3):366-98
references.pmid: 16102838
references.citation: Prog Nucleic Acid Res Mol Biol. 2001;66:241-77
references.pmid: 11051766
references.citation: Lipids Health Dis. 2003 Oct 29;2:8
references.pmid: 14613579
references.citation: Am J Physiol Cell Physiol. 2001 Oct;281(4):C1158-64
references.pmid: 11546651
references.citation: Diabetologia. 1997 Feb;40(2):238-43
references.pmid: 9049487
references.citation: Diabetes Care. 2008 Feb;31(2):347-52
references.pmid: 18000184
references.citation: Diabetes. 1986 Jan;35(1):101-5
references.pmid: 3510133
references.citation: J Hypertens. 2005 Dec;23(12):2119-25
references.pmid: 16269951